Journal: Vaccines
Article Title: Development of Pandemic Vaccines: ERVEBO Case Study
doi: 10.3390/vaccines9030190
Figure Lengend Snippet: Summary of clinical trial programs.
Article Snippet: V920-013 PREPARE US, Canada NCT02788227 , Randomized open-label, booster or no booster at 18 months in individuals at potential occupational risk , [NIH/NIAID] BARDA, University of Texas, Galveston, TX, Emory University, PHAC, Winnipeg; CIRN, University of Nebraska Medical Center, Boston Medical Center/Boston University, Universitätsklinikum Hamburg-Eppendorf , Planned enrollment N up to 1000 , 2 × 10 7 , Yes , N/A , Day 1–14, Month 1, Month 18 (booster), Month 19 (post-booster) , Day 1–42 , Day 1 to Year 3 , Not collected , Not collected.
Techniques: Injection